Benefits, issues, and recommendations for personalized medicine in oncology in Canada
about
L'émergence de la thérapeutique de précision: de nouveaux défis et de nouvelles possibilités pour les leaders en santé du Canada.The emergence of precision therapeutics: New challenges and opportunities for Canada's health leaders.ENVIRONMENTAL SCAN ON PHARMACEUTICALS REQUIRING COMPANION DIAGNOSTICS.Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.Experience of nursing support from the perspective of patients with cancer in mainland China.Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.
P2860
Benefits, issues, and recommendations for personalized medicine in oncology in Canada
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Benefits, issues, and recommendations for personalized medicine in oncology in Canada
@en
Benefits, issues, and recommendations for personalized medicine in oncology in Canada.
@nl
type
label
Benefits, issues, and recommendations for personalized medicine in oncology in Canada
@en
Benefits, issues, and recommendations for personalized medicine in oncology in Canada.
@nl
prefLabel
Benefits, issues, and recommendations for personalized medicine in oncology in Canada
@en
Benefits, issues, and recommendations for personalized medicine in oncology in Canada.
@nl
P2093
P2860
P356
P1433
P1476
Benefits, issues, and recommendations for personalized medicine in oncology in Canada
@en
P2093
C Desjardins
F D Ashbury
M B Sawyer
P2860
P304
P356
10.3747/CO.20.1253
P577
2013-10-01T00:00:00Z